…ECHA updates its registered substances database

Toxicity information on over 4000 registered substances may be accessed through ECHA’s registered substances database, which was updated in July 2011. This database can be accessed at http://apps.echa.europa.eu/registered/registered-sub.aspx on the ECHA website. {188217}

…Proposals for harmonised classification and labelling

Under EC Regulation No. 1272/2008 on Classification, Labelling and Packaging (CLP), there is a legal obligation for suppliers to evaluate the hazards of chemicals (substances and mixtures) to be placed on the market, and to classify and label them appropriately. An option also exists for Member State Competent Authorities or industry to ask for the classification and labelling of a substance to be harmonised across Europe, whereupon ECHA organises a public consultation period of 45 days. Under this scheme, proposals have been recently submitted by the Austrian, Danish, German and UK authorities to standardise the classification of five compounds, amidosulfuron, 3-iodo-2-propynyl butylcarbamate (IPBC), tebufenpyrad, acrolein and triadimenol. Visit the ECHA website (at to view the background scientific reports, obtain further information, or comment on these proposals (by 12 September 2011). {188222-6}

…Other REACH items of interest

 

Updated guidance on requirements for substances in articles now available in 22 EU languages (http://guidance.echa.europa.eu/guidance_en.htm).

Dedicated pages for downstream users are now provided in 22 EU languages (http://guidance.echa.europa.eu/docs/guidance_document/du_en.htm).

Testing proposals involving vertebrate animals: request for information from third parties on over 50 substances (15 July 2011; 29 July 2011; 1 August 2011) (http://echa.europa.eu/consultations/test_proposals/test_prop_cons_en.asp?consultations_status=current).

The above items were taken from the September 2011 issue of Toxicology and Regulatory News which is sent automatically to members of bibra (click here for more details).

News Home Guest Write For Us? Contact Us